Novel GPC-3 Targeted Therapies Require Hepatocellular Carcinoma Tissue Evaluation for GPC-3 Status: A Plea to Reinstitute Biopsy Procurement After Diagnostic Multiphase Imaging

Sivanandham, S; Jakate, S

MODERN PATHOLOGY, 2022; 35 (SUPPL 2): 1157